Skip to main content
. 2023 Jun 29;13(6):e065369. doi: 10.1136/bmjopen-2022-065369

Figure 1.

Figure 1

Overview of COMBINE study intervention. Overview of COMBINE study activities, comparing interventions delivered in South Tarawa (pink, intervention group) and in the rest of Kiribati (green, no intervention group). Activities are further divided according to those available at baseline across the country and continued during the study period, and those activities that will be delivered during the study period (vertical arrows at right). Geographical context is illustrated at top (not to scale). 3HP, 3 months of weekly isoniazid and rifapentine; 3RH, 3 months of daily isoniazid and rifampicin; ACF, active case finding; DST, drug susceptibility testing; MDA, mass drug administration; MDT, multidrug treatment; NLP, National Leprosy Programme; PEP, postexposure prophylaxis; SDR, single-dose rifampicin; TB, tuberculosis; TPT, TB preventive treatment.